In addition, CD1c+ cDC from the SF of patients with RA are characterized by preferential expression of IL-1β, IL-8, and CCL3 and by higher functional abilities to induce pathogenic IL-17+IFN-γ+ T cell responses in vitro compared with other synovial myeloid subsets. The gene discussed is IL1B; the disease is rheumatoid arthritis.